In accordance with Section 287(a) of Title 35 of the United States Code, the following list identifies Cytokinetics’ rights in U.S. patents associated with the relevant product. This list may be a subset of Cytokinetics’ rights in U.S. patents directed to the relevant product. Each product may also be protected by one or more foreign patents.
The contents of the table shown below are subject to change due to issuance, licensing or expiration of patent rights, product changes or launches and other circumstances. The absence of a product or a U.S. Patent number from this list does not constitute a waiver of Cytokinetics’ patent, trademark, or other intellectual property rights concerning that product or patent.
| Product | Patent Number |
|---|---|
| MYQORZO™ | U.S. 10,836,755 U.S. 12,370,179 U.S. 11,932,631 U.S. 12,065,436 U.S. 12,247,024 |
Revised on December 10, 2025